Connect with us
BioNTech is a biotechnology company that is working towards revolutionary new cancer treatment methods. The company is headquartered in the upper city of Mainz and has...
In the biotechnology sector, buyouts and licensing agreements are almost always accompanied by development milestones and other milestone payments. Analysts have attempted to quantify the share...
The sale of the biotechnology group Qiagen from Hilden in North Rhine-Westphalia is off the table for the time being. After fruitless talks with interested parties,...
With the Yoyo, the Italian startup XEV plans to launch a light, inexpensive electric car that is perfect for the city by the end of 2020....
The Mainz-based company BioNTech develops individualized cancer drugs. The company has raised billions of U.S. dollars on the U.S. technology exchange Nasdaq. BioNtech is a rarity,...
The Liège-based biotech company PDC*line Pharma, which specializes in immuno-oncology, has initiated a Phase I/II study to evaluate a therapeutic vaccine against lung cancer. This cancer...
The Neutraubling-based mechanical engineering company expects a return on sales before taxes of only 1% and not 3% as previously estimated. According to the CEO of...
Immunos Therapeutics, from the Universities of Zurich and Basel, has received new funds from a financing round. On top of that Daniel Vasella, former CEO of...
Regeneron Pharmaceuticals Inc shares rebounded as investors found out about collaboration partner Sanofi SA’s liquidation of its Regeneron stake. The two companies also plan to restructure...
Aiming to attract global advanced biotechnology companies and research institutions, the Incheon City authorities will expand the industrial complex the Songdo Global Biotech Cluster. They are...